Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder

International Clinical Psychopharmacology

Volumn 18, Issue 3, 2003, Pages 151-156

  Clayton, Anita H ^a,f   Zajecka, John ^b   Ferguson, James M ^c   Filipiak Reisner, Jacqueline K ^d   Brown, Mark T ^d   Schwartz, Gerri E ^d,e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d PFIZER INC   (United States)

^e Columbia Univ Coll of Phys/Surgs ^*  (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Fluoxetine; Reboxetine; Selective noradrenaline reuptake inhibitor; Selective serotonin reuptake inhibitor; Sexual dysfunction

Indexed keywords

FLUOXETINE; PLACEBO; REBOXETINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; ORGASM; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PATIENT COMPLIANCE; PATIENT SATISFACTION; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 0038402607     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200305000-00005     Document Type: Article

References (15)

1. Aizenberg D, Zemishlany Z, Weizman A (1995). Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 18;320-324.
2. Baldwin D (2001). Depression and sexual dysfunction. Br Med Bull 57:81-99.
3. Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC (2002a). Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry 62:185-190.
4. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson, C, et al. (2002b). Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63:357-366.
5. Ferguson JM (2001). The effects of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry 62 (suppl 3):22-34.
6. Ferguson M, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, et al. (2001). Re-emergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry 62:24-29.
7. Giuliano F, Rampin O (2000). Central noradrenergic control of penile erection. Int J Impot Res 12 (suppl. 1):S13-S19.
8. Hamilton M (1967). Development of a rating scale for primary depressive illness. Dr J Soc Psychol 6:278-296.
9. Harvey KV, Balon R (1995). Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 7:189-201.
10. Montejo AL, Llorca G, Izquierdo J, Rico-Villademoros F (2001). Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J. Clin Psychiatry 62 (suppl. 3):10-21.
11. Philipp M, Tiller JW, Baier D, Kohnen R (2000). Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. Eur Neuropsychopharmacol 10:305-314.
12. Rabkin JG, Quitkin FM, McGrath P, Harrison W, Tricamo E (1985). Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical managements. J Clin Psychopharmacol 5:2-9.
13. Thase ME, Nofzinger E, Reynolds CF, Faziczka AL, Jennings JR, Frank E (1994). Effect of antidepressant treatment on sexual function in depressed men. Psychopharmacol Bull 30:83.
14. Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG (1993). Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 54:459-465.
15. Zajecka J, Mitchell S, Fawcett J (1997). Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull 33:755-760.